Diagnostics

Mutation markers: improved diagnostics for neuropathologies

Mutation markers: improved diagnostics for neuropathologies

Learn how MilliporeSigma is expanding its tissue diagnostic antibody portfolio to help better classify gliomas and other nervous system tumors Each cancer is characterized by a unique set of genetic alterations, including amplifications, rearrangements, translocations or indels (additions or deletions). These alterations lead to tumor development and can be used as markers to define tumor …

Mutation markers: improved diagnostics for neuropathologies Read More »

ASSURANCE HALLMARK CONSOLIDÉE : TRIMESTRE 3 - ÉTATS FINANCIERS 2022 |  MarketScreener

Houston Concierge Medicine Partners with Cardio Diagnostics to Offer the Epi+Gen CHD Test in its Executive Health Program | MarketScreener

The leading concierge medicine practice in Houston will be the first concierge medicine practice to offer the Epi+Gen CHD precision test for cardiovascular disease to executives in Houston, TX. Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), a leading precision cardiovascular diagnostics company, and Houston Concierge Medicine, a leading medical practice serving executives and health-conscious consumers in …

Houston Concierge Medicine Partners with Cardio Diagnostics to Offer the Epi+Gen CHD Test in its Executive Health Program | MarketScreener Read More »

Say yes to annual wellness diagnostics and oral microbiome testing

Say yes to annual wellness diagnostics and oral microbiome testing

A clinician’s approach to persuading clients to be proactive with preventive diagnoses As a feline practitioner, I see a lot of sick cats. The most difficult cases always involve felines whose owners say they “have not been to the vet in years and have recently stopped eating”. We are doing lab work and, congratulations, your …

Say yes to annual wellness diagnostics and oral microbiome testing Read More »

The holy grail of precision medicine - co-development of companion therapeutics and diagnostics - has yet to reach its potential

The holy grail of precision medicine – co-development of companion therapeutics and diagnostics – has yet to reach its potential

The doctor offers a personalized drug through a genomic test. Getty At the Illumina Genomics Forum conference this fall, former President Obama explained that precision medicine has a “significant role to play in making the healthcare system more efficient and producing better outcomes,” but it has yet to realize its full potential. Indeed, precision medicine …

The holy grail of precision medicine – co-development of companion therapeutics and diagnostics – has yet to reach its potential Read More »

Europe Precision Diagnostics Market Report 2022: The Era of Personalized Medicine is Dawning, Fueling Industry Growth

Europe Precision Diagnostics Market Report 2022: The Era of Personalized Medicine is Dawning, Fueling Industry Growth

Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) — The report “Europe Precision Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End User” has been added to from ResearchAndMarkets.com offer. Europe Precision Diagnostics Market is expected to grow from US$23,317.64 million in 2022 to US$48,500.85 million by 2028. It …

Europe Precision Diagnostics Market Report 2022: The Era of Personalized Medicine is Dawning, Fueling Industry Growth Read More »